New Faces in the Fight Against Lymphoma: A Commitment to Change
March 2, 2025, 5:42 pm
The Lymphoma Research Foundation (LRF) is stepping up its game. Recently, two new members joined its Board of Directors: Ellen M. Walker and Whitney Neighbors. Both women bring unique perspectives and experiences to the table. Their stories are not just about professional achievements; they are deeply personal. They are warriors in the battle against lymphoma, each with a mission to change lives.
Ellen M. Walker, a prominent attorney from Aventura, Florida, is no stranger to loss. After losing her son, Paul, to non-Hodgkin lymphoma, she turned her grief into action. She founded The Paul Foundation, focusing on the needs of adolescent and young adult (AYA) lymphoma patients. This initiative is a beacon of hope for a demographic often overlooked in cancer care. Ellen’s personal journey fuels her passion. She understands the emotional and physical toll of lymphoma. Her commitment to the cause is palpable.
Whitney Neighbors, hailing from Houston, Texas, is a lymphoma survivor. Her experience with Diffuse Large B-Cell Lymphoma (DLBCL) in 2018 transformed her life. She emerged from treatment not just as a survivor but as an advocate. Whitney’s role as Chief Trust Officer at Woodland Advisors adds a layer of expertise to her advocacy. She knows the ins and outs of legal and financial matters, making her a valuable asset to the LRF.
Both women share a common goal: to improve the lives of lymphoma patients. They join a board filled with business leaders and medical professionals. Together, they form a powerful alliance. Their collective experience will help steer the LRF towards innovative research and effective patient support.
The LRF is the largest non-profit organization dedicated to lymphoma research. Its mission is clear: to fund groundbreaking research and provide education and resources to the lymphoma community. With Ellen and Whitney on board, the foundation is poised for growth. Their leadership will enhance the organization’s outreach and impact.
Ellen’s focus on AYA patients is crucial. This age group faces unique challenges. They often feel isolated in their battles. Traditional cancer support systems may not cater to their specific needs. Ellen’s initiative aims to bridge that gap. By collaborating with the LRF, she is ensuring that young patients receive the care they deserve.
Whitney’s perspective as a survivor adds depth to the board. She knows the struggles firsthand. Her journey through treatment equips her with insights that can guide the foundation’s efforts. She understands the fears, the uncertainties, and the hope that comes with survival. Her voice will resonate with patients and caregivers alike.
The LRF is not just about research; it’s about community. It provides education programs, outreach initiatives, and patient services. These resources are vital for those navigating the complexities of lymphoma. The foundation aims to create a supportive environment where patients can thrive. With Ellen and Whitney’s contributions, this mission will gain momentum.
The importance of advocacy cannot be overstated. Both women are committed to raising awareness about lymphoma. They will help shine a light on the disease, encouraging more people to understand its impact. Education is a powerful tool. It can lead to earlier diagnoses and better treatment options.
Fundraising is another critical aspect of the LRF’s work. Ellen’s experience in philanthropy will be instrumental. She has organized numerous fundraising events, collaborating with luxury brands and community partners. Her skills will help secure the necessary funds for research and patient support programs.
Whitney’s role in the LRF will also focus on patient resources. She has already made strides in this area as Chair of the Lymphoma Epidemiology of Outcomes (LEO) Participant Advisory Council. Her leadership in this capacity demonstrates her commitment to patient advocacy. She knows what resources are needed and how to access them.
The challenges faced by lymphoma patients are significant. They often battle not just the disease but also the emotional and financial burdens that come with it. The LRF aims to alleviate some of these pressures. With Ellen and Whitney’s guidance, the foundation can expand its reach and enhance its offerings.
The addition of these two women to the Board of Directors is a game-changer. Their personal stories and professional expertise will help shape the future of the LRF. They are not just board members; they are champions for change. Their dedication to the lymphoma community is unwavering.
As the LRF moves forward, it will continue to prioritize innovative research and patient support. The foundation’s mission is more important than ever. With Ellen and Whitney at the helm, there is hope for a brighter future for lymphoma patients. Their combined efforts will ensure that no one faces this battle alone.
In conclusion, the Lymphoma Research Foundation is entering a new chapter. With the election of Ellen M. Walker and Whitney Neighbors, the foundation is poised for growth and impact. Their stories are a testament to resilience and advocacy. Together, they will work tirelessly to improve the lives of those affected by lymphoma. The fight against this disease is far from over, but with leaders like Ellen and Whitney, there is hope on the horizon.
Ellen M. Walker, a prominent attorney from Aventura, Florida, is no stranger to loss. After losing her son, Paul, to non-Hodgkin lymphoma, she turned her grief into action. She founded The Paul Foundation, focusing on the needs of adolescent and young adult (AYA) lymphoma patients. This initiative is a beacon of hope for a demographic often overlooked in cancer care. Ellen’s personal journey fuels her passion. She understands the emotional and physical toll of lymphoma. Her commitment to the cause is palpable.
Whitney Neighbors, hailing from Houston, Texas, is a lymphoma survivor. Her experience with Diffuse Large B-Cell Lymphoma (DLBCL) in 2018 transformed her life. She emerged from treatment not just as a survivor but as an advocate. Whitney’s role as Chief Trust Officer at Woodland Advisors adds a layer of expertise to her advocacy. She knows the ins and outs of legal and financial matters, making her a valuable asset to the LRF.
Both women share a common goal: to improve the lives of lymphoma patients. They join a board filled with business leaders and medical professionals. Together, they form a powerful alliance. Their collective experience will help steer the LRF towards innovative research and effective patient support.
The LRF is the largest non-profit organization dedicated to lymphoma research. Its mission is clear: to fund groundbreaking research and provide education and resources to the lymphoma community. With Ellen and Whitney on board, the foundation is poised for growth. Their leadership will enhance the organization’s outreach and impact.
Ellen’s focus on AYA patients is crucial. This age group faces unique challenges. They often feel isolated in their battles. Traditional cancer support systems may not cater to their specific needs. Ellen’s initiative aims to bridge that gap. By collaborating with the LRF, she is ensuring that young patients receive the care they deserve.
Whitney’s perspective as a survivor adds depth to the board. She knows the struggles firsthand. Her journey through treatment equips her with insights that can guide the foundation’s efforts. She understands the fears, the uncertainties, and the hope that comes with survival. Her voice will resonate with patients and caregivers alike.
The LRF is not just about research; it’s about community. It provides education programs, outreach initiatives, and patient services. These resources are vital for those navigating the complexities of lymphoma. The foundation aims to create a supportive environment where patients can thrive. With Ellen and Whitney’s contributions, this mission will gain momentum.
The importance of advocacy cannot be overstated. Both women are committed to raising awareness about lymphoma. They will help shine a light on the disease, encouraging more people to understand its impact. Education is a powerful tool. It can lead to earlier diagnoses and better treatment options.
Fundraising is another critical aspect of the LRF’s work. Ellen’s experience in philanthropy will be instrumental. She has organized numerous fundraising events, collaborating with luxury brands and community partners. Her skills will help secure the necessary funds for research and patient support programs.
Whitney’s role in the LRF will also focus on patient resources. She has already made strides in this area as Chair of the Lymphoma Epidemiology of Outcomes (LEO) Participant Advisory Council. Her leadership in this capacity demonstrates her commitment to patient advocacy. She knows what resources are needed and how to access them.
The challenges faced by lymphoma patients are significant. They often battle not just the disease but also the emotional and financial burdens that come with it. The LRF aims to alleviate some of these pressures. With Ellen and Whitney’s guidance, the foundation can expand its reach and enhance its offerings.
The addition of these two women to the Board of Directors is a game-changer. Their personal stories and professional expertise will help shape the future of the LRF. They are not just board members; they are champions for change. Their dedication to the lymphoma community is unwavering.
As the LRF moves forward, it will continue to prioritize innovative research and patient support. The foundation’s mission is more important than ever. With Ellen and Whitney at the helm, there is hope for a brighter future for lymphoma patients. Their combined efforts will ensure that no one faces this battle alone.
In conclusion, the Lymphoma Research Foundation is entering a new chapter. With the election of Ellen M. Walker and Whitney Neighbors, the foundation is poised for growth and impact. Their stories are a testament to resilience and advocacy. Together, they will work tirelessly to improve the lives of those affected by lymphoma. The fight against this disease is far from over, but with leaders like Ellen and Whitney, there is hope on the horizon.